EBS Latest Headlines

Emergent BioSolutions Secures $22.3 Million Anthrax Vaccine Contract Modification

at www.tipranks.com (Wed, 4-Nov 4:47 PM)

Emergent BioSolutions reports Q3 2026 revenue inline with guidance, but margins turned sharply negative

Market Chameleon (Tue, 3-Nov 9:10 AM)

Emergent BioSolutions Flags a Long-Run CFO Transition, Naming Frank Vargo Interim CFO Starting 2027

Market Chameleon (Fri, 16-Oct 8:32 AM)